Table of Contents

September/October 2005; Volume 59,Issue 5

  1. Andrieu, J.

    1. Optimization of the Freeze-Drying Cycle: Adaptation of the Pressure Rise Analysis Model to Non-Instantaneous Isolation Valves
      P. Chouvenc, S. Vessot, J. Andrieu and P. Vacus
      PDA Journal of Pharmaceutical Science and Technology September 2005, 59 (5) 298-309;

  2. Beijnen, Jos H.

    1. Pharmaceutical Development of a Parenteral Lyophilised Dosage Form for the Novel Anticancer Agent C1311
      Monique W. J. Den Brok, Bastiaan Nuijen, J. Jantina Kettenes-Van Den Bosch, M. J. Van Steenbergen, Josie N. Buluran, Michael D. Harvey, Charles K. Grieshaber and Jos H. Beijnen
      PDA Journal of Pharmaceutical Science and Technology September 2005, 59 (5) 285-297;

  3. Buluran, Josie N.

    1. Pharmaceutical Development of a Parenteral Lyophilised Dosage Form for the Novel Anticancer Agent C1311
      Monique W. J. Den Brok, Bastiaan Nuijen, J. Jantina Kettenes-Van Den Bosch, M. J. Van Steenbergen, Josie N. Buluran, Michael D. Harvey, Charles K. Grieshaber and Jos H. Beijnen
      PDA Journal of Pharmaceutical Science and Technology September 2005, 59 (5) 285-297;

  4. Chouvenc, P.

    1. Optimization of the Freeze-Drying Cycle: Adaptation of the Pressure Rise Analysis Model to Non-Instantaneous Isolation Valves
      P. Chouvenc, S. Vessot, J. Andrieu and P. Vacus
      PDA Journal of Pharmaceutical Science and Technology September 2005, 59 (5) 298-309;

  5. Den Brok, Monique W. J.

    1. Pharmaceutical Development of a Parenteral Lyophilised Dosage Form for the Novel Anticancer Agent C1311
      Monique W. J. Den Brok, Bastiaan Nuijen, J. Jantina Kettenes-Van Den Bosch, M. J. Van Steenbergen, Josie N. Buluran, Michael D. Harvey, Charles K. Grieshaber and Jos H. Beijnen
      PDA Journal of Pharmaceutical Science and Technology September 2005, 59 (5) 285-297;

  6. Grieshaber, Charles K.

    1. Pharmaceutical Development of a Parenteral Lyophilised Dosage Form for the Novel Anticancer Agent C1311
      Monique W. J. Den Brok, Bastiaan Nuijen, J. Jantina Kettenes-Van Den Bosch, M. J. Van Steenbergen, Josie N. Buluran, Michael D. Harvey, Charles K. Grieshaber and Jos H. Beijnen
      PDA Journal of Pharmaceutical Science and Technology September 2005, 59 (5) 285-297;

  7. Harvey, Michael D.

    1. Pharmaceutical Development of a Parenteral Lyophilised Dosage Form for the Novel Anticancer Agent C1311
      Monique W. J. Den Brok, Bastiaan Nuijen, J. Jantina Kettenes-Van Den Bosch, M. J. Van Steenbergen, Josie N. Buluran, Michael D. Harvey, Charles K. Grieshaber and Jos H. Beijnen
      PDA Journal of Pharmaceutical Science and Technology September 2005, 59 (5) 285-297;

  8. Kettenes-van Den Bosch, J. Jantina

    1. Pharmaceutical Development of a Parenteral Lyophilised Dosage Form for the Novel Anticancer Agent C1311
      Monique W. J. Den Brok, Bastiaan Nuijen, J. Jantina Kettenes-Van Den Bosch, M. J. Van Steenbergen, Josie N. Buluran, Michael D. Harvey, Charles K. Grieshaber and Jos H. Beijnen
      PDA Journal of Pharmaceutical Science and Technology September 2005, 59 (5) 285-297;

  9. Leo, Frank

    1. Impact of Blow/Fill/Seal Process Variables in Determining Rate of Vial Contamination by Air Dispersed Microorganisms
      Frank Leo, Patrick Poisson, Colin S. Sinclair and Alan Tallentire
      PDA Journal of Pharmaceutical Science and Technology September 2005, 59 (5) 320-331;

  10. Meneces, Nora S.

    1. Statistical Properties of the USP Dissolution Test with Pooled Samples
      Carlos D. Saccone, Nora S. Meneces and Julio Tessore
      PDA Journal of Pharmaceutical Science and Technology September 2005, 59 (5) 310-319;
« Previous (Pages : 1 2 3 ... 3) Next »
Back to top

In This Issue